Amundi Has $62.18 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

Key Points

• Amundi increased its Healthpeak Properties stake by 7% in the first quarter, acquiring 249,227 additional shares. Its position totaled 3.78 million shares worth approximately $62.2 million, while institutions collectively own 93.57% of DOC.
• Healthpeak reported quarterly EPS of $0.45, exceeding estimates of $0.43, while revenue rose 7.1% year over year to $752.95 million. The company issued fiscal 2026 EPS guidance of $1.71–$1.75.
• The REIT announced a monthly dividend of $0.1017 per share, representing a 5.6% annualized yield. Analysts maintain a consensus “Hold” rating with a $20.62 price target, despite several firms raising their targets to $24.

Amundi raised its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 7.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,784,577 shares of the real estate investment trust's stock after purchasing an additional 249,227 shares during the period. Amundi owned approximately 0.55% of Healthpeak Properties worth $62,181,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. WPG Advisers LLC grew its holdings in shares of Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust's stock valued at $26,000 after purchasing an additional 1,197 shares during the last quarter. Advocate Investing Services LLC acquired a new stake in Healthpeak Properties in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC bought a new stake in shares of Healthpeak Properties during the fourth quarter worth $31,000. Clearstead Advisors LLC grew its stake in shares of Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust's stock worth $31,000 after buying an additional 1,216 shares during the last quarter. Finally, CYBER HORNET ETFs LLC acquired a new position in shares of Healthpeak Properties during the second quarter worth $33,000. 93.57% of the stock is currently owned by institutional investors.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company's stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares of the company's stock, valued at approximately $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.23% of the stock is currently owned by insiders.

Healthpeak Properties Trading Down 0.0%

NYSE DOC opened at $21.83 on Monday. The firm has a market capitalization of $15.05 billion, a PE ratio of 68.21, a price-to-earnings-growth ratio of 3.39 and a beta of 1.01. The business's 50-day moving average price is $21.01 and its two-hundred day moving average price is $18.66. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.95.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same period last year, the company earned $0.46 earnings per share. The firm's revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, analysts expect that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.6%. Healthpeak Properties's payout ratio is presently 381.25%.

Wall Street Analyst Weigh In

DOC has been the subject of a number of recent research reports. BMO Capital Markets upped their target price on Healthpeak Properties from $20.00 to $24.00 and gave the stock an "outperform" rating in a report on Monday, June 15th. Raymond James Financial began coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They set a "market perform" rating on the stock. Robert W. Baird boosted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the stock an "outperform" rating in a report on Wednesday, May 13th. Mizuho upped their price objective on Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, July 6th. Finally, Evercore lowered shares of Healthpeak Properties from an "outperform" rating to an "in-line" rating and set a $21.00 price objective for the company. in a report on Monday, May 11th. Four equities research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $20.62.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.